Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA-Binding Protein EWS | 11 | 2024 | 211 | 2.220 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 5 | 2023 | 104 | 1.820 |
Why?
|
Oncogene Proteins, Fusion | 14 | 2024 | 1613 | 1.540 |
Why?
|
Wilms Tumor | 7 | 2024 | 378 | 1.170 |
Why?
|
Chromatin | 13 | 2024 | 2981 | 1.140 |
Why?
|
In Situ Hybridization | 12 | 2021 | 1903 | 0.880 |
Why?
|
Gene Expression Regulation, Neoplastic | 21 | 2024 | 8647 | 0.810 |
Why?
|
Bone Neoplasms | 6 | 2021 | 2565 | 0.730 |
Why?
|
Tumor Suppressor Proteins | 10 | 2016 | 2810 | 0.720 |
Why?
|
Karyopherins | 2 | 2024 | 134 | 0.690 |
Why?
|
Microsatellite Repeats | 2 | 2018 | 785 | 0.640 |
Why?
|
Odontogenic Tumors | 3 | 2024 | 48 | 0.560 |
Why?
|
Gene Silencing | 2 | 2018 | 1505 | 0.560 |
Why?
|
Calmodulin-Binding Proteins | 2 | 2019 | 238 | 0.560 |
Why?
|
Otx Transcription Factors | 1 | 2017 | 42 | 0.560 |
Why?
|
Enhancer Elements, Genetic | 3 | 2018 | 1367 | 0.540 |
Why?
|
Chromatin Assembly and Disassembly | 4 | 2020 | 633 | 0.530 |
Why?
|
Genes, Wilms Tumor | 2 | 2007 | 92 | 0.530 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2024 | 859 | 0.520 |
Why?
|
WT1 Proteins | 4 | 2024 | 183 | 0.520 |
Why?
|
Medulloblastoma | 2 | 2019 | 683 | 0.490 |
Why?
|
Adenocarcinoma, Clear Cell | 3 | 2021 | 218 | 0.490 |
Why?
|
RNA-Binding Proteins | 3 | 2020 | 1890 | 0.470 |
Why?
|
Salivary Gland Neoplasms | 3 | 2024 | 306 | 0.470 |
Why?
|
Ventricular Remodeling | 2 | 2019 | 1281 | 0.460 |
Why?
|
Myocardial Contraction | 1 | 2019 | 1525 | 0.460 |
Why?
|
Hepatoblastoma | 1 | 2013 | 90 | 0.420 |
Why?
|
Sirtuins | 3 | 2022 | 322 | 0.420 |
Why?
|
DNA | 5 | 2023 | 7214 | 0.420 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2013 | 99 | 0.410 |
Why?
|
Sarcoma, Clear Cell | 2 | 2024 | 72 | 0.410 |
Why?
|
RNA, Small Interfering | 5 | 2019 | 3428 | 0.410 |
Why?
|
Cell Line, Tumor | 27 | 2024 | 17140 | 0.400 |
Why?
|
Cerebellar Neoplasms | 1 | 2017 | 591 | 0.390 |
Why?
|
Adaptor Proteins, Signal Transducing | 9 | 2015 | 2909 | 0.380 |
Why?
|
Transcription, Genetic | 6 | 2022 | 7608 | 0.360 |
Why?
|
Myocardium | 3 | 2019 | 4788 | 0.360 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2024 | 432 | 0.340 |
Why?
|
Sarcoma, Synovial | 2 | 2021 | 156 | 0.330 |
Why?
|
Chromosomes, Human, X | 2 | 2007 | 320 | 0.300 |
Why?
|
Myocardial Ischemia | 2 | 2015 | 2138 | 0.290 |
Why?
|
Kidney Neoplasms | 5 | 2024 | 4282 | 0.280 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3941 | 0.270 |
Why?
|
Protein Isoforms | 4 | 2024 | 1715 | 0.260 |
Why?
|
Mesenchymal Stem Cells | 4 | 2018 | 1672 | 0.250 |
Why?
|
Wnt Proteins | 3 | 2016 | 725 | 0.240 |
Why?
|
Spheroids, Cellular | 2 | 2024 | 331 | 0.240 |
Why?
|
Transcription Factors | 9 | 2022 | 12168 | 0.240 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2024 | 33 | 0.230 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2023 | 454 | 0.230 |
Why?
|
Gene Expression Profiling | 5 | 2020 | 9538 | 0.230 |
Why?
|
Antigens, Nuclear | 2 | 2015 | 183 | 0.230 |
Why?
|
SOXB1 Transcription Factors | 2 | 2016 | 286 | 0.220 |
Why?
|
Liver Neoplasms | 3 | 2015 | 4362 | 0.220 |
Why?
|
Neoplastic Stem Cells | 4 | 2017 | 1351 | 0.220 |
Why?
|
Sequence Analysis, RNA | 6 | 2017 | 2040 | 0.220 |
Why?
|
Gene Deletion | 5 | 2018 | 2675 | 0.210 |
Why?
|
Multiprotein Complexes | 4 | 2020 | 1110 | 0.210 |
Why?
|
Soft Tissue Neoplasms | 2 | 2022 | 1164 | 0.210 |
Why?
|
Cardiomyopathies | 1 | 2015 | 2056 | 0.200 |
Why?
|
Cyclin D1 | 1 | 2024 | 453 | 0.200 |
Why?
|
Hydrazines | 1 | 2024 | 223 | 0.200 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 223 | 0.190 |
Why?
|
Pharmacy | 1 | 2023 | 92 | 0.190 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2022 | 91 | 0.190 |
Why?
|
RNA, Untranslated | 2 | 2018 | 455 | 0.190 |
Why?
|
Adenocarcinoma | 5 | 2020 | 6395 | 0.190 |
Why?
|
Salivary Glands | 2 | 2021 | 231 | 0.190 |
Why?
|
Cell Transformation, Neoplastic | 6 | 2023 | 2846 | 0.180 |
Why?
|
Single-Cell Analysis | 5 | 2021 | 2540 | 0.180 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2017 | 1143 | 0.180 |
Why?
|
Epigenesis, Genetic | 5 | 2020 | 3833 | 0.180 |
Why?
|
Interferons | 2 | 2022 | 720 | 0.170 |
Why?
|
Kidney | 5 | 2010 | 7064 | 0.170 |
Why?
|
Nuclear Proteins | 4 | 2022 | 5804 | 0.170 |
Why?
|
RNA, Viral | 2 | 2021 | 2872 | 0.170 |
Why?
|
Fibrillar Collagens | 1 | 2019 | 42 | 0.170 |
Why?
|
Animals | 36 | 2024 | 169246 | 0.170 |
Why?
|
Humans | 79 | 2024 | 768166 | 0.160 |
Why?
|
Cysteine | 1 | 2024 | 897 | 0.160 |
Why?
|
Mice | 29 | 2024 | 82029 | 0.160 |
Why?
|
DNA-Binding Proteins | 6 | 2022 | 9615 | 0.160 |
Why?
|
Jaw Neoplasms | 1 | 2019 | 71 | 0.160 |
Why?
|
Cell Survival | 4 | 2017 | 5777 | 0.160 |
Why?
|
Retinoblastoma Protein | 1 | 2022 | 671 | 0.160 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11519 | 0.160 |
Why?
|
Aniline Compounds | 2 | 2015 | 1094 | 0.150 |
Why?
|
Triazoles | 1 | 2024 | 904 | 0.150 |
Why?
|
Retroperitoneal Space | 1 | 2019 | 175 | 0.150 |
Why?
|
Mandibular Neoplasms | 1 | 2019 | 131 | 0.150 |
Why?
|
Skull Neoplasms | 1 | 2019 | 173 | 0.150 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2019 | 119 | 0.150 |
Why?
|
Viral Vaccines | 1 | 2003 | 596 | 0.150 |
Why?
|
Neoplasms | 7 | 2024 | 22371 | 0.150 |
Why?
|
Facial Bones | 1 | 2019 | 209 | 0.150 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 559 | 0.150 |
Why?
|
DNA Contamination | 1 | 2017 | 19 | 0.150 |
Why?
|
Pancreatic Neoplasms | 4 | 2019 | 5446 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 6 | 2018 | 4528 | 0.140 |
Why?
|
RANK Ligand | 1 | 2019 | 321 | 0.140 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6124 | 0.140 |
Why?
|
Lung Neoplasms | 6 | 2023 | 13586 | 0.140 |
Why?
|
Papillomaviridae | 1 | 2003 | 1140 | 0.140 |
Why?
|
Dystrophin | 1 | 2018 | 284 | 0.140 |
Why?
|
Prolactin | 1 | 2019 | 627 | 0.140 |
Why?
|
Immunohistochemistry | 6 | 2021 | 11095 | 0.140 |
Why?
|
Barrett Esophagus | 1 | 2020 | 495 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 362 | 0.140 |
Why?
|
Stromal Cells | 2 | 2019 | 1336 | 0.130 |
Why?
|
Gene Rearrangement | 2 | 2019 | 1146 | 0.130 |
Why?
|
Apoptosis | 7 | 2024 | 9523 | 0.130 |
Why?
|
Liposarcoma | 1 | 2019 | 289 | 0.130 |
Why?
|
Protein Binding | 5 | 2020 | 9343 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2024 | 1266 | 0.130 |
Why?
|
Repressor Proteins | 3 | 2016 | 2982 | 0.130 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2021 | 2521 | 0.130 |
Why?
|
Gene Expression Regulation | 5 | 2016 | 11928 | 0.130 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2015 | 1151 | 0.130 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2016 | 182 | 0.130 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2015 | 83 | 0.130 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2020 | 1247 | 0.130 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2015 | 26 | 0.120 |
Why?
|
Principal Component Analysis | 2 | 2017 | 948 | 0.120 |
Why?
|
Fibrosis | 2 | 2019 | 2080 | 0.120 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2015 | 171 | 0.120 |
Why?
|
RNA Interference | 3 | 2019 | 2832 | 0.120 |
Why?
|
Azacitidine | 1 | 2017 | 336 | 0.120 |
Why?
|
Oligodendroglioma | 1 | 2016 | 274 | 0.120 |
Why?
|
Human papillomavirus 18 | 1 | 2015 | 125 | 0.120 |
Why?
|
Point Mutation | 3 | 2016 | 1596 | 0.120 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2017 | 781 | 0.120 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3948 | 0.120 |
Why?
|
Cancer Vaccines | 1 | 2022 | 1041 | 0.120 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1837 | 0.120 |
Why?
|
Sulfonamides | 2 | 2015 | 1982 | 0.120 |
Why?
|
Morpholines | 2 | 2015 | 584 | 0.110 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2017 | 951 | 0.110 |
Why?
|
Human papillomavirus 16 | 1 | 2015 | 268 | 0.110 |
Why?
|
Sequence Analysis, DNA | 2 | 2023 | 4786 | 0.110 |
Why?
|
Cell Lineage | 3 | 2019 | 2575 | 0.110 |
Why?
|
Mice, SCID | 2 | 2019 | 2627 | 0.110 |
Why?
|
Cell Differentiation | 9 | 2023 | 11669 | 0.110 |
Why?
|
beta Catenin | 2 | 2010 | 1047 | 0.110 |
Why?
|
Leukemia, Myeloid | 1 | 2016 | 693 | 0.110 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1027 | 0.110 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 183 | 0.100 |
Why?
|
Carcinoma | 1 | 2024 | 2332 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2022 | 2954 | 0.100 |
Why?
|
Pyridines | 1 | 2024 | 2894 | 0.100 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2013 | 271 | 0.100 |
Why?
|
RNA, Messenger | 7 | 2018 | 12800 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2015 | 2333 | 0.100 |
Why?
|
Promoter Regions, Genetic | 4 | 2022 | 5797 | 0.100 |
Why?
|
Lung | 2 | 2021 | 10099 | 0.100 |
Why?
|
Albumins | 1 | 2014 | 577 | 0.100 |
Why?
|
Zebrafish Proteins | 1 | 2018 | 1019 | 0.100 |
Why?
|
Antigen Presentation | 3 | 2002 | 1251 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3671 | 0.100 |
Why?
|
Serum Albumin | 1 | 2015 | 677 | 0.090 |
Why?
|
Female | 35 | 2024 | 397192 | 0.090 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2003 | 2043 | 0.090 |
Why?
|
p300-CBP Transcription Factors | 1 | 2012 | 148 | 0.090 |
Why?
|
DNA, Satellite | 1 | 2011 | 67 | 0.090 |
Why?
|
Introns | 1 | 2013 | 966 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 2 | 2019 | 8128 | 0.090 |
Why?
|
Male | 28 | 2021 | 364719 | 0.090 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2014 | 0.090 |
Why?
|
Autoantigens | 1 | 2015 | 890 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 620 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 3 | 2013 | 5703 | 0.090 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 1083 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1668 | 0.090 |
Why?
|
Trans-Activators | 2 | 2022 | 2857 | 0.090 |
Why?
|
Sarcoma | 1 | 2021 | 1806 | 0.090 |
Why?
|
Receptors, Androgen | 1 | 2016 | 1089 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2019 | 1757 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2023 | 313 | 0.080 |
Why?
|
Meningioma | 1 | 2018 | 1220 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2104 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2830 | 0.080 |
Why?
|
Translocation, Genetic | 2 | 2022 | 1394 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2024 | 3611 | 0.080 |
Why?
|
Sequence Deletion | 1 | 2013 | 1497 | 0.080 |
Why?
|
Membrane Proteins | 5 | 2015 | 7876 | 0.080 |
Why?
|
Genomics | 3 | 2019 | 5926 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 2018 | 1253 | 0.080 |
Why?
|
Cholangiocarcinoma | 1 | 2014 | 561 | 0.080 |
Why?
|
Bile Duct Neoplasms | 1 | 2014 | 614 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2429 | 0.080 |
Why?
|
Oncogenes | 3 | 2022 | 1234 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 945 | 0.080 |
Why?
|
Lectins, C-Type | 2 | 2002 | 594 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6974 | 0.080 |
Why?
|
Signal Transduction | 6 | 2024 | 23645 | 0.080 |
Why?
|
Mice, Nude | 5 | 2013 | 3623 | 0.070 |
Why?
|
RNA, Neoplasm | 1 | 2011 | 749 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2015 | 2062 | 0.070 |
Why?
|
Binding Sites | 3 | 2023 | 6020 | 0.070 |
Why?
|
Chromosome Deletion | 2 | 2016 | 1385 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 952 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 801 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2015 | 1625 | 0.070 |
Why?
|
Cell Cycle Proteins | 4 | 2024 | 3445 | 0.070 |
Why?
|
Base Sequence | 2 | 2016 | 12421 | 0.070 |
Why?
|
Colonic Neoplasms | 2 | 2017 | 2541 | 0.070 |
Why?
|
Transfection | 2 | 2019 | 5755 | 0.070 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2007 | 247 | 0.070 |
Why?
|
Prostatic Neoplasms | 3 | 2019 | 11101 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2018 | 19015 | 0.070 |
Why?
|
Collagen | 1 | 2015 | 2643 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1738 | 0.070 |
Why?
|
HEK293 Cells | 4 | 2019 | 4283 | 0.070 |
Why?
|
DNA Methylation | 3 | 2017 | 4428 | 0.070 |
Why?
|
Glycoproteins | 2 | 2016 | 2202 | 0.070 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 13676 | 0.070 |
Why?
|
Cell Line | 3 | 2013 | 15597 | 0.070 |
Why?
|
Melanoma | 2 | 2024 | 5706 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2015 | 1681 | 0.070 |
Why?
|
Dendritic Cells | 3 | 2002 | 2747 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1656 | 0.060 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 1481 | 0.060 |
Why?
|
Biopsy | 4 | 2020 | 6793 | 0.060 |
Why?
|
Disease Models, Animal | 4 | 2019 | 18349 | 0.060 |
Why?
|
Adenoma | 1 | 2016 | 2159 | 0.060 |
Why?
|
Cell Proliferation | 5 | 2020 | 10474 | 0.060 |
Why?
|
RNA | 3 | 2022 | 2720 | 0.060 |
Why?
|
Breast Neoplasms | 3 | 2023 | 21206 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 4413 | 0.060 |
Why?
|
Intestinal Mucosa | 1 | 2016 | 3044 | 0.060 |
Why?
|
Child | 10 | 2023 | 80917 | 0.060 |
Why?
|
Automation, Laboratory | 2 | 2015 | 102 | 0.060 |
Why?
|
Child, Preschool | 5 | 2019 | 42669 | 0.060 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 2 | 2016 | 85 | 0.060 |
Why?
|
Protein Stability | 2 | 2020 | 580 | 0.060 |
Why?
|
Workflow | 2 | 2022 | 860 | 0.060 |
Why?
|
Adult | 13 | 2021 | 223646 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5432 | 0.060 |
Why?
|
Middle Aged | 15 | 2021 | 223492 | 0.060 |
Why?
|
Fatty Acids | 1 | 2012 | 1812 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2017 | 9118 | 0.060 |
Why?
|
SOXE Transcription Factors | 1 | 2024 | 73 | 0.060 |
Why?
|
Glioblastoma | 3 | 2014 | 3464 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2013 | 2433 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1640 | 0.050 |
Why?
|
Aged | 12 | 2021 | 171504 | 0.050 |
Why?
|
Head and Neck Neoplasms | 2 | 2015 | 2931 | 0.050 |
Why?
|
Stem Cells | 1 | 2016 | 3537 | 0.050 |
Why?
|
Organoids | 2 | 2020 | 743 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2006 | 506 | 0.050 |
Why?
|
Databases, Bibliographic | 1 | 2003 | 128 | 0.050 |
Why?
|
Carrier Proteins | 3 | 2014 | 4937 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2015 | 4058 | 0.050 |
Why?
|
Genes, BRCA1 | 1 | 2006 | 755 | 0.050 |
Why?
|
E2F1 Transcription Factor | 1 | 2022 | 182 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4793 | 0.050 |
Why?
|
Neoplasm Proteins | 2 | 2013 | 3603 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2006 | 564 | 0.050 |
Why?
|
E2F Transcription Factors | 1 | 2022 | 270 | 0.050 |
Why?
|
Glioma | 1 | 2017 | 3503 | 0.050 |
Why?
|
Cell Nucleolus | 1 | 2022 | 156 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15454 | 0.050 |
Why?
|
Prognosis | 3 | 2019 | 30010 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5863 | 0.050 |
Why?
|
Life Cycle Stages | 1 | 2022 | 161 | 0.050 |
Why?
|
Epigenomics | 2 | 2020 | 960 | 0.050 |
Why?
|
Acetylation | 2 | 2016 | 1056 | 0.050 |
Why?
|
RNA, Ribosomal | 1 | 2022 | 227 | 0.050 |
Why?
|
Gene Expression | 4 | 2011 | 7598 | 0.050 |
Why?
|
Mutation | 6 | 2023 | 30238 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2022 | 321 | 0.050 |
Why?
|
Lamivudine | 1 | 2022 | 367 | 0.040 |
Why?
|
Intestines | 2 | 2022 | 1909 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2010 | 13421 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2018 | 9561 | 0.040 |
Why?
|
Gene Regulatory Networks | 2 | 2024 | 1752 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2020 | 151 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5341 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2892 | 0.040 |
Why?
|
Heterozygote | 1 | 2007 | 2798 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2015 | 710 | 0.040 |
Why?
|
Medical Oncology | 2 | 2022 | 2346 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4580 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 17622 | 0.040 |
Why?
|
Heart Failure | 2 | 2015 | 11879 | 0.040 |
Why?
|
Phlebitis | 1 | 2019 | 35 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 2048 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 2 | 2016 | 1062 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9419 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 308 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 66 | 0.040 |
Why?
|
Calcium | 1 | 2012 | 5792 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 19 | 0.040 |
Why?
|
Alleles | 2 | 2007 | 6894 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 398 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2023 | 581 | 0.040 |
Why?
|
Adenovirus E1A Proteins | 1 | 2018 | 81 | 0.040 |
Why?
|
Integrins | 1 | 2023 | 842 | 0.040 |
Why?
|
Histones | 2 | 2020 | 2601 | 0.040 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2059 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 59629 | 0.040 |
Why?
|
RNA Stability | 1 | 2020 | 319 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2227 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2002 | 4648 | 0.040 |
Why?
|
Glycolysis | 1 | 2022 | 837 | 0.040 |
Why?
|
Immunoblotting | 2 | 2012 | 1647 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2022 | 549 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3803 | 0.040 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2022 | 606 | 0.040 |
Why?
|
Mucins | 1 | 2020 | 570 | 0.040 |
Why?
|
Phosphoproteins | 2 | 2021 | 2451 | 0.040 |
Why?
|
DNA, Neoplasm | 2 | 2014 | 1744 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2010 | 858 | 0.040 |
Why?
|
Doxorubicin | 1 | 2024 | 2234 | 0.040 |
Why?
|
Th1 Cells | 1 | 2022 | 1042 | 0.030 |
Why?
|
Antigens | 1 | 2002 | 1442 | 0.030 |
Why?
|
NIH 3T3 Cells | 2 | 2010 | 669 | 0.030 |
Why?
|
Ligands | 1 | 2024 | 3284 | 0.030 |
Why?
|
Mice, Knockout | 5 | 2016 | 14488 | 0.030 |
Why?
|
Mice, Inbred C57BL | 5 | 2010 | 22379 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 565 | 0.030 |
Why?
|
Autopsy | 1 | 2020 | 1011 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 319 | 0.030 |
Why?
|
Liposomes | 1 | 2000 | 790 | 0.030 |
Why?
|
Th2 Cells | 1 | 2022 | 1078 | 0.030 |
Why?
|
Mucin-2 | 1 | 2016 | 50 | 0.030 |
Why?
|
RNA Probes | 1 | 2016 | 111 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2020 | 3703 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 687 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 598 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10873 | 0.030 |
Why?
|
Clone Cells | 1 | 2020 | 1670 | 0.030 |
Why?
|
Receptors, Cell Surface | 2 | 2002 | 2819 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 717 | 0.030 |
Why?
|
Apolipoproteins A | 1 | 2016 | 96 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2002 | 1361 | 0.030 |
Why?
|
Dinoprostone | 1 | 2019 | 597 | 0.030 |
Why?
|
Macrophages | 3 | 2020 | 5799 | 0.030 |
Why?
|
Genome, Human | 2 | 2010 | 4446 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 778 | 0.030 |
Why?
|
U937 Cells | 1 | 2015 | 260 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2493 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2016 | 174 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 599 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1120 | 0.030 |
Why?
|
Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 17 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2015 | 130 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1340 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2017 | 229 | 0.030 |
Why?
|
Antigens, CD | 2 | 2002 | 4035 | 0.030 |
Why?
|
Protein Transport | 1 | 2020 | 1951 | 0.030 |
Why?
|
Osteonectin | 1 | 2014 | 33 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 874 | 0.030 |
Why?
|
Membrane Glycoproteins | 2 | 2002 | 3711 | 0.030 |
Why?
|
Immunity | 1 | 2020 | 1003 | 0.030 |
Why?
|
Retinal Dehydrogenase | 1 | 2014 | 78 | 0.030 |
Why?
|
Arginase | 1 | 2015 | 81 | 0.030 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2016 | 361 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2016 | 534 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1245 | 0.030 |
Why?
|
Down-Regulation | 2 | 2013 | 2937 | 0.030 |
Why?
|
Antigens, CD1 | 1 | 1997 | 434 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 464 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 757 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11878 | 0.030 |
Why?
|
Steroids | 1 | 2019 | 938 | 0.030 |
Why?
|
Piperazines | 1 | 2024 | 2554 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2002 | 2323 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3436 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2019 | 1191 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 190 | 0.030 |
Why?
|
Genes, ras | 1 | 2016 | 663 | 0.030 |
Why?
|
England | 1 | 2015 | 533 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 751 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2019 | 4568 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.030 |
Why?
|
Caspase 3 | 1 | 2015 | 730 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 60066 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2016 | 658 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2022 | 4415 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2016 | 1524 | 0.030 |
Why?
|
Disease Progression | 2 | 2020 | 13671 | 0.030 |
Why?
|
Kinetics | 1 | 2020 | 6329 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2013 | 255 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1673 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2013 | 412 | 0.020 |
Why?
|
Cerebellum | 1 | 2019 | 1522 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13014 | 0.020 |
Why?
|
RNA Splicing | 1 | 2016 | 905 | 0.020 |
Why?
|
Adolescent | 4 | 2021 | 89169 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3396 | 0.020 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 88 | 0.020 |
Why?
|
Phenotype | 4 | 2019 | 16726 | 0.020 |
Why?
|
Computational Biology | 1 | 2003 | 3568 | 0.020 |
Why?
|
PPAR alpha | 1 | 2012 | 177 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2002 | 303 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2016 | 2065 | 0.020 |
Why?
|
Neuroglia | 1 | 2016 | 960 | 0.020 |
Why?
|
DEAD-box RNA Helicases | 1 | 2013 | 385 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2001 | 5505 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1754 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1135 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20227 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2023 | 81762 | 0.020 |
Why?
|
Prostate | 1 | 2018 | 1765 | 0.020 |
Why?
|
Lentivirus | 1 | 2013 | 518 | 0.020 |
Why?
|
Ovalbumin | 2 | 2002 | 677 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2016 | 820 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4146 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3073 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2678 | 0.020 |
Why?
|
Proteomics | 1 | 2003 | 3912 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2015 | 1271 | 0.020 |
Why?
|
Neurosecretory Systems | 1 | 2011 | 223 | 0.020 |
Why?
|
Phosphorylation | 2 | 2013 | 8317 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 895 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2015 | 936 | 0.020 |
Why?
|
Genetic Variation | 1 | 2004 | 6611 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2410 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2843 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2011 | 332 | 0.020 |
Why?
|
DNA, Viral | 1 | 2015 | 2204 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 1997 | 1815 | 0.020 |
Why?
|
Calcium Channels | 1 | 2012 | 623 | 0.020 |
Why?
|
Fibroblasts | 1 | 2019 | 4176 | 0.020 |
Why?
|
Prostatectomy | 1 | 2016 | 1786 | 0.020 |
Why?
|
Heterochromatin | 1 | 2011 | 294 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 2012 | 797 | 0.020 |
Why?
|
ras Proteins | 1 | 2013 | 1058 | 0.020 |
Why?
|
Luciferases | 1 | 2010 | 713 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2013 | 5902 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1376 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2010 | 577 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2828 | 0.020 |
Why?
|
Reference Values | 1 | 2015 | 4938 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 874 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2211 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5027 | 0.020 |
Why?
|
Tight Junctions | 1 | 2010 | 324 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2007 | 351 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2007 | 3800 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7453 | 0.020 |
Why?
|
Infant | 2 | 2019 | 36535 | 0.020 |
Why?
|
Cell Polarity | 1 | 2010 | 639 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 1406 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2862 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2010 | 910 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39348 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4755 | 0.020 |
Why?
|
Fetus | 1 | 2013 | 1883 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4206 | 0.020 |
Why?
|
Podocytes | 1 | 2010 | 403 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 1305 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54926 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6847 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2015 | 22291 | 0.020 |
Why?
|
Proteins | 1 | 2000 | 6009 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1767 | 0.020 |
Why?
|
Karyotyping | 1 | 2007 | 1177 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1968 | 0.020 |
Why?
|
Astrocytes | 1 | 2013 | 1350 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 788 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2010 | 1105 | 0.020 |
Why?
|
Retroviridae | 1 | 2007 | 846 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2013 | 2885 | 0.010 |
Why?
|
Genes, Duplicate | 1 | 2004 | 31 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5367 | 0.010 |
Why?
|
Receptors, Estradiol | 1 | 2003 | 18 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2001 | 10266 | 0.010 |
Why?
|
Rabbits | 1 | 2010 | 4772 | 0.010 |
Why?
|
Software Validation | 1 | 2003 | 59 | 0.010 |
Why?
|
MEDLINE | 1 | 2003 | 119 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1250 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10760 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9374 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5210 | 0.010 |
Why?
|
Cohort Studies | 2 | 2018 | 41754 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2011 | 2885 | 0.010 |
Why?
|
Muramidase | 1 | 2001 | 163 | 0.010 |
Why?
|
Gene Amplification | 1 | 2006 | 1095 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2015 | 3301 | 0.010 |
Why?
|
Tetanus Toxin | 1 | 2000 | 46 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2603 | 0.010 |
Why?
|
Drug Stability | 1 | 2000 | 291 | 0.010 |
Why?
|
Lymph Nodes | 2 | 2002 | 3474 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2012 | 3841 | 0.010 |
Why?
|
Gene Dosage | 1 | 2004 | 1219 | 0.010 |
Why?
|
Neurons | 1 | 2019 | 9514 | 0.010 |
Why?
|
United States | 2 | 2020 | 73039 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65371 | 0.010 |
Why?
|
Drug Compounding | 1 | 2000 | 241 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24315 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3610 | 0.010 |
Why?
|
Rats | 1 | 2015 | 23760 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1055 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4120 | 0.010 |
Why?
|
Endocytosis | 1 | 2002 | 956 | 0.010 |
Why?
|
Zebrafish | 1 | 2010 | 3035 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2000 | 825 | 0.010 |
Why?
|
Disease | 1 | 2003 | 675 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18065 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15948 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2003 | 1758 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2003 | 2732 | 0.010 |
Why?
|
Spleen | 1 | 2001 | 2295 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4916 | 0.010 |
Why?
|
Lymphocytes | 1 | 2001 | 2614 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2000 | 2633 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2003 | 2709 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1997 | 812 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1997 | 2300 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2000 | 1930 | 0.010 |
Why?
|
Thymus Gland | 1 | 1997 | 1266 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36743 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12795 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2000 | 2232 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2003 | 3781 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2007 | 26422 | 0.000 |
Why?
|
Bipolar Disorder | 1 | 2003 | 5130 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 9263 | 0.000 |
Why?
|
Hypertension | 1 | 2003 | 8616 | 0.000 |
Why?
|
Algorithms | 1 | 2003 | 14164 | 0.000 |
Why?
|
Models, Biological | 1 | 1997 | 9495 | 0.000 |
Why?
|